Immunomodulation by Interleukin-10 Therapy Decreases the Incidence of Relapse and Prolongs the Relapse-free Interval in Psoriasis

Severe Psoriasis – Oral Therapy with a New Retinoid

T Fredriksson, U. Pettersson · Dermatologica · 2009 · 2.7K citations

Medicine, Dermatology, Pharmacology +11

IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells

Megan K. Levings, Romina Sangregorio, Francesca Galbiati et al. · The Journal of Immunology · 2001 · 591 citations

Life Sciences, Cell Biology, Immunology +17

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

SJ van Deventer, CO Elson · Gastroenterology · 1997 · 489 citations · Full text

Life Sciences, Immunology, Immunopathology +13

The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated Response

Koichi Uyemura, Masahiro Yamamura, David F Fivenson et al. · Journal of Investigative Dermatology · 1993 · 459 citations

Medicine, Dermatology, Immunology +17

A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses.

Amy Chernoff, Eric V. Granowitz, Leland Shapiro et al. · The Journal of Immunology · 1995 · 421 citations

Life Sciences, Immunology, Pharmacotherapy +15